The First Crispr Treatment Is Making Its Way to Patients
It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder. It’s finally being infused into patients.
It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder. It’s finally being infused into patients.
What's Your Reaction?
Hemanth Kumar Gorle
Mr. Hemanth Kumar Gorle, founder of Indian Web Services, specializes in web development, hosting, and online marketing. He is dedicated to creating effective digital solutions and fostering successful business relationships through his expertise and strategic approach.
